相似文献
1
A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single copy probe p144-D6 [HGM9 No. D17S34].
Nucleic Acids Res. 1987 Dec 23;15(24):10605. doi: 10.1093/nar/15.24.10605.
2
Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.
Genomics. 1994 Sep 1;23(1):229-32. doi: 10.1006/geno.1994.1481.
3
An anonymous single-copy clone, pC63, from chromosome 17q23-qter identifies a frequent RFLP [HGM9 No. D17S21].
Nucleic Acids Res. 1987 Nov 11;15(21):9096. doi: 10.1093/nar/15.21.9096.
4
An anonymous single-copy clone, p30-1-60, identifies a frequent RFLP on chromosome 3p [HGM9 no. D3S86].
Nucleic Acids Res. 1989 Apr 11;17(7):2883. doi: 10.1093/nar/17.7.2883.
5
An anonymous single-copy clone, p55-B1, from chromosome 17 identifies a TaqI RFLP [HGM9 no. D17S86].
Nucleic Acids Res. 1989 Mar 25;17(6):2371. doi: 10.1093/nar/17.6.2371.
6
Multi-allelic RFLP for M27 beta, an anonymous single copy genomic clone at Xp11.3-Xcen [HGM9 provisional no. DXS255].
Nucleic Acids Res. 1987 Nov 25;15(22):9616. doi: 10.1093/nar/15.22.9616.
7
Cosmid 128 defines three RFLPs on chromosome 17q23-qter. [HGM9 no. D17S77].
Nucleic Acids Res. 1988 Jul 11;16(13):6251. doi: 10.1093/nar/16.13.6251.
8
A polymorphic human myosin heavy chain locus is linked to an anonymous single copy locus (D17S1) at 17p13.
Cytogenet Cell Genet. 1986;43(1-2):117-20. doi: 10.1159/000132307.
9
Clinical and molecular diagnosis of Miller-Dieker syndrome.
Am J Hum Genet. 1991 Mar;48(3):584-94.
10
Cosmid 1-26 defines four RFLPs on chromosome 17q23-qter [HGM9 No. D17S20].
Nucleic Acids Res. 1987 Nov 11;15(21):9097. doi: 10.1093/nar/15.21.9097.
引用本文的文献
1
Map refinement of locus RP13 to human chromosome 17p13.3 in a second family with autosomal dominant retinitis pigmentosa.
Am J Hum Genet. 1996 Feb;58(2):347-55.
2
Loss of alleles in brain tumours: distribution and correlations with clinical course.
J Neurol. 1995 Oct;242(10):707-11. doi: 10.1007/BF00866924.
3
Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
Br J Cancer. 1993 May;67(5):1007-10. doi: 10.1038/bjc.1993.184.
4
p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
Am J Pathol. 1993 Nov;143(5):1398-405.
5
Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.
Am J Pathol. 1994 Jun;144(6):1312-9.
6
Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.
Ann Hematol. 1994 Jan;68(1):3-7. doi: 10.1007/BF01695912.
7
High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.
Am J Pathol. 1993 Sep;143(3):845-56.
8
Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
Br J Cancer. 1994 Dec;70(6):1176-81. doi: 10.1038/bjc.1994.468.
9
TP53 allele loss, mutations and expression in malignant melanoma.
Br J Cancer. 1994 Feb;69(2):253-9. doi: 10.1038/bjc.1994.48.
10
Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.
Br J Cancer. 1995 Mar;71(3):438-41. doi: 10.1038/bjc.1995.89.
本文引用的文献
1
Progress towards construction of a total restriction fragment map of a human chromosome.
Nucleic Acids Res. 1987 Feb 25;15(4):1363-75. doi: 10.1093/nar/15.4.1363.
Zotero 插件